February 2020 | Blog
News & Announcements
February 2020 | Statement
In a just world, we would all have the resources we need—including information, services, supportive policies, and power—to make the best choices for ourselves, our families, and our communities, to choose whether and when to have children, and to raise those children with dignity. Yet...
November 2019 | Statement
At Ibis, justice and equity are core values that guide our research and partnerships and shape our vision for sexual and reproductive autonomy, choices, and health worldwide. In 2016, we launched work to ensure that Ibis’s work and approach are situated within a larger framework of racial...
September 2019 | Statement
Euki, from Ibis Reproductive Health and Women Help Women, protects users’ private data CAMBRIDGE, Mass. – A recently released smartphone app offers a new model of health information and tracking technology. Euki, built using research from Ibis Reproductive Health and released by Women...
June 2019 | Statement
We are pleased to announce the appointment of Thoai Ngo as chair of Ibis’s Board of Directors. As director of the Population Council’s Poverty, Gender, and Youth Program, Thoai oversees efforts to develop and test innovative solutions and scale up successful strategies to improve the...
June 2019 | Statement
We are delighted to announce that Brigitte Amiri, deputy director of the ACLU Reproductive Freedom Project, has joined Ibis’s Board of Directors as a member at large. Brigitte is currently leading critical litigation on sexual and reproductive health, rights, and justice, including the Jane...
May 2019 | Statement
On May 9, 1960, the US Food and Drug Administration first approved the birth control pill, which helped give people the freedom to determine their own life path. Nearly 60 years later, it’s past time to make the pill truly accessible. The pill is safe and effective, but one in three women who...
April 2019 | Statement
In 2014, a bill (S.B. 1391) was passed that allowed the state of Tennessee to arrest pregnant women for the illegal use of narcotics during pregnancy if the child was born exposed to or harmed by the drug. Those arrested and charged under the Fetal Assault Law faced a penalty of up to fifteen years...
April 2019 | Statement
Ibis stands with our partners around the world in recognition of International Day for Maternal Health and Rights. We remain steadfast in our commitment to advance sexual and reproductive autonomy, choices, and health through bold, rigorous research and principled partnerships with advocates,...
February 2019 | Statement
CAMBRIDGE, Mass. — Today, Kelly Blanchard, President of Ibis Reproductive Health, released the statement below about the current administration’s sweeping changes to Title X. “On Friday, the Trump administration continued its attacks on people’s—and especially women...
February 2019 | Statement
A new Texas Policy Evaluation Project (TxPEP) study shows that use of medication abortion, also known as “the abortion pill,” bounced back in Texas after a March 2016 label change by the US Food and Drug Administration (FDA). The label change impacted the use of mifepristone, one of the...
January 2019 | Statement
CAMBRIDGE, Mass. — Today, Kelly Blanchard, President of Ibis Reproductive Health, released the statement below about New York’s new law to protect and expand reproductive health and rights, throughout pregnancy. “ New York state law now permits abortions to be ‘performed by...